OpenScience.ink

4 weeks ago • Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Negative Mouth and Saliva Effects Linked to Glucagon-Like Peptide-1 Receptor Agonist MedicationsAdverse Oral and Salivary Effects Associated With Glucagon-Like Peptide-1 Receptor Agonists: Clinical Insights.

📖 Top 30% JournalArticle

4 weeks ago • Alzheimer's & dementia : the journal of the Alzheimer's Association

Genetic evidence suggests activating brain GLP-1 receptors may protect thinking areas in Alzheimer's diseaseGenetic evidence supports a cortical neuroprotective role of GLP-1 receptor activation in Alzheimer's disease: A drug-target Mendelian randomization study.

🥈 Top 2% JournalArticle

4 weeks ago • Cell metabolism

UBT251, a new treatment activating three hormone receptors, tested in adults with overweight or obesity in a phase 2 trialUBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial.

🥇 Top 1% JournalArticle

4 weeks ago • Molecular metabolism

Specific brain neurons help control nausea caused by incretin hormones but do not affect appetite or weight lossParabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss.

🥉 Top 5% JournalArticle

4 weeks ago • Clinical nutrition ESPEN

Natural Foods That May Influence Weight Control by Affecting a Key Hormone ReceptorInsights into natural dietary components as indirect modulators of glucagon-like Peptide-1 receptor signaling in weight management.

📖 Top 30% JournalArticle

4 weeks ago • Explore (New York, N.Y.)

Why GLP-1 therapy works better for some patients: an Ayurvedic view on metabolic differencesWhy do some patients thrive on GLP-1 therapy while others do not? An ayurvedic perspective on metabolic heterogeneity.

📖 Top 50% JournalArticle

4 weeks ago • American heart journal

Design and starting details of the CagriSema heart health outcomes trial (REDEFINE 3)Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3).

🥉 Top 5% JournalArticle

4 weeks ago • Obesity research & clinical practice

Changes over time in use of diabetes medications during pregnancy in Manitoba, Canada, 2015-2023Temporal trends in GLP-1 receptor agonist and SGLT2 inhibitor dispensing during pregnancy in Manitoba, Canada, 2015-2023.

📖 Top 20% JournalLetter

4 weeks ago • Clinical and translational gastroenterology

US Healthcare Professionals' Management of Fatty Liver Disease and Knowledge of Hormone-Based Diabetes TreatmentsUS Healthcare Professionals' Management of MASH and Knowledge of GLP-1, GIP, and Glucagon Receptor Agonists.

📖 Top 20% JournalArticle

4 weeks ago • Sleep & breathing = Schlaf & Atmung

GLP-1 receptor drugs and their effects on obstructive sleep apnea: a combined analysis of clinical trialsGLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials.

📖 Top 30% JournalSystematic Review

← prevpage 15 of 16next →

Latest GLP-1 Therapies Research Papers